These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15681796)

  • 1. Gamma-delta T cells as orally induced suppressor cells in rats: in vitro characterization.
    Wildner G; Thurau SR; Diedrichs-Möhring M
    Ann N Y Acad Sci; 2004 Dec; 1029():416-21. PubMed ID: 15681796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally induced, peptide-specific gamma/delta TCR+ cells suppress experimental autoimmune uveitis.
    Wildner G; Hünig T; Thurau SR
    Eur J Immunol; 1996 Sep; 26(9):2140-8. PubMed ID: 8814259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen.
    Laliotou B; Duncan L; Dick AD
    J Autoimmun; 1999 May; 12(3):145-55. PubMed ID: 10222024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease.
    Wildner G; Thurau SR
    Eur J Immunol; 1994 Nov; 24(11):2579-85. PubMed ID: 7957552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunostimulatory and immunomodulatory peptides derived from the alpha1 domain of HLA-B27 in experimental autoimmune diseases in Lewis rats.
    Diedrichs-Möhring M; Wildner G
    Immunobiology; 2005; 209(10):711-7. PubMed ID: 15969447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats.
    Breban M; Fernández-Sueiro JL; Richardson JA; Hadavand RR; Maika SD; Hammer RE; Taurog JD
    J Immunol; 1996 Jan; 156(2):794-803. PubMed ID: 8543835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential recognition of a retinal autoantigen peptide and its variants by rat T cells in vitro and in vivo.
    Wildner G; Diedrichs-Möhring M
    Int Immunol; 2003 Aug; 15(8):927-35. PubMed ID: 12882830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis.
    Gregerson DS; Torseth JW; McPherson SW; Roberts JP; Shinohara T; Zack DJ
    J Immunol; 1999 Jul; 163(2):1073-80. PubMed ID: 10395707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regulation of the contact sensitivity reaction by suppression of T gamma delta lymphocytes].
    Szczepanik M
    Folia Med Cracov; 1998; 39(1-2):5-33. PubMed ID: 10481375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligopeptides of three to five residues derived from uveitopathogenic sites of retinal S-antigen induce experimental autoimmune uveitis (EAU) in Lewis rats.
    Sunil S; Eto K; Singh VK; Shinohara T
    Cell Immunol; 1993 Apr; 148(1):198-207. PubMed ID: 8495487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with recombinant Escherichia coli expressing retinal S-antigen-induced experimental autoimmune uveitis (EAU) in Lewis rats.
    Eto K; Suzuki S; Singh VK; Shinohara T
    Cell Immunol; 1993 Mar; 147(1):203-14. PubMed ID: 8462112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat models of autoimmune uveitis.
    Wildner G; Diedrichs-Mohring M; Thurau SR
    Ophthalmic Res; 2008; 40(3-4):141-4. PubMed ID: 18421228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of experimental autoimmune uveitis in Lewis rats by oral administration of recombinant Escherichia coli expressing retinal S-antigen.
    Singh VK; Anand R; Sharma K; Agarwal SS
    Cell Immunol; 1996 Sep; 172(2):158-62. PubMed ID: 8964076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis.
    Kurhan-Yavuz S; Direskeneli H; Bozkurt N; Ozyazgan Y; Bavbek T; Kazokoglu H; Eksioglu-Demiralp E; Wildner G; Diedrichs-Möhring M; Akoglu T
    Clin Exp Immunol; 2000 Apr; 120(1):162-6. PubMed ID: 10759778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen--first results.
    Thurau SR; Diedrichs-Möhring M; Fricke H; Arbogast S; Wildner G
    Immunol Lett; 1997 Jun; 57(1-3):193-201. PubMed ID: 9232451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rodent models of experimental autoimmune uveitis.
    Agarwal RK; Caspi RR
    Methods Mol Med; 2004; 102():395-419. PubMed ID: 15286397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mimicry. Yeast histone H3-induced experimental autoimmune uveitis.
    Singh VK; Yamaki K; Donoso LA; Shinohara T
    J Immunol; 1989 Mar; 142(5):1512-7. PubMed ID: 2645363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a suppressor cell line which downgrades experimental autoimmune uveoretinitis in the rat.
    Caspi RR; Kuwabara T; Nussenblatt RB
    J Immunol; 1988 Apr; 140(8):2579-84. PubMed ID: 2965724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of oral tolerance induction with HLA-peptide B27PD in patients with uveitis.
    Thurau SR; Fricke H; Burchardi C; Diedrichs-Möhring M; Wildner G
    Ann N Y Acad Sci; 2004 Dec; 1029():408-12. PubMed ID: 15681794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of arthritis and uveitis in Lewis rats by antigenic mimicry of peptides from HLA-B27 and cytokeratin.
    Wildner G; Diedrichs-Möhring M; Thurau SR
    Eur J Immunol; 2002 Jan; 32(1):299-306. PubMed ID: 11782021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.